Oral delivery of an ustekinumab biosimilar with bioavailability comparable to subcutaneous administration in healthy human participants. - Myers JT; Yamaguchi A; Horlen K; Fung LC; Vo AT; Mohan D; Hoopes M; Imran M; Van Dam J; Gonen OM; Hashim MA; Dhalla AK; et al. (European journal of clinical pharmacology, 2026)